Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.

Source:http://linkedlifedata.com/resource/pubmed/id/10569763

Download in:

View as

General Info

PMID
10569763